Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL KNIGHT PIPER

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1760412035
CMS profile
124669
Location
THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$4,255.20

229 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,255.20 229

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 229 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL KNIGHT PIPER

NPI 1760412035 · CMS profile ID 124669

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 229 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1760412035?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL KNIGHT PIPER, NPI 1760412035, CMS profile ID 124669. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 229 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1760412035?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). PAUL KNIGHT PIPER, NPI 1760412035, CMS profile ID 124669. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 229 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1760412035?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
PAUL KNIGHT PIPER, NPI 1760412035, CMS profile ID 124669, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 229 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1760412035?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

229 matching records · $4,255.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 229 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 229.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Esperion Therapeutics, Inc. $6.6507/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376073 CMS
Clarus Therapeutics Inc. $16.3107/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855026545 CMS
Lilly USA, LLC $14.0207/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818714493 CMS
Alexion Pharmaceuticals, Inc. $18.2707/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783108907 CMS
Zealand Pharma US, Inc. $46.3507/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229619 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.5407/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850355681 CMS
Esperion Therapeutics, Inc. $13.9907/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376069 CMS
Endo Pharmaceuticals Inc. $24.3207/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828670327 CMS
SANOFI-AVENTIS U.S. LLC $14.5607/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843569917 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.9307/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763630110 CMS
Zealand Pharma US, Inc. $31.8507/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229617 CMS
Corcept Therapeutics $15.7307/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837527165 CMS
Esperion Therapeutics, Inc. $6.6907/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376065 CMS
Xeris Pharmaceuticals, Inc. $23.7807/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837440415 CMS
Novo Nordisk Inc $8.6507/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811125617 CMS
Amgen Inc. $14.9706/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825680127 CMS
Lilly USA, LLC $13.6406/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 856542965 CMS
AstraZeneca Pharmaceuticals LP $24.2006/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829362655 CMS
AstraZeneca Pharmaceuticals LP $14.5406/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829274875 CMS
Novo Nordisk Inc $23.6406/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811685257 CMS
Esperion Therapeutics, Inc. $6.4506/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376061 CMS
AbbVie Inc. $15.0806/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795653681 CMS
Zealand Pharma US, Inc. $26.0306/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229615 CMS
Acerus Pharmaceuticals Corporation $14.8706/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777476795 CMS
Amneal Pharmaceuticals LLC $14.5706/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829673883 CMS
AstraZeneca Pharmaceuticals LP $23.2706/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830024445 CMS
SANOFI-AVENTIS U.S. LLC $15.6406/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843569865 CMS
Esperion Therapeutics, Inc. $5.9506/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376057 CMS
MannKind Corporation $18.3006/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821075157 CMS
Merck Sharp & Dohme Corporation $18.4906/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848734327 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.9906/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763630112 CMS
AstraZeneca Pharmaceuticals LP $20.8606/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829515175 CMS
Corcept Therapeutics $21.6706/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837527155 CMS
Esperion Therapeutics, Inc. $6.6206/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376053 CMS
Ultragenyx Pharmaceutical Inc. $24.9206/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976045 CMS
Lilly USA, LLC $0.6905/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818714487 CMS
Lilly USA, LLC $19.0605/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818714665 CMS
Zealand Pharma US, Inc. $27.8805/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229613 CMS
Novo Nordisk Inc $8.0005/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811125609 CMS
Antares Pharma, Inc. $14.0805/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827501939 CMS
MannKind Corporation $23.7105/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821075153 CMS
Novo Nordisk Inc $19.8405/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811125603 CMS
Zealand Pharma US, Inc. $5.5605/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229611 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.7405/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850317523 CMS
Xeris Pharmaceuticals, Inc. $19.6505/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837440409 CMS
Becton, Dickinson and Company $19.4805/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836112557 CMS
Esperion Therapeutics, Inc. $5.4705/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838376047 CMS
Acerus Pharmaceuticals Corporation $11.3705/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777476025 CMS
AstraZeneca Pharmaceuticals LP $18.7205/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829806225 CMS
Abbott Laboratories $21.4905/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815486447 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,421.63 192
PY2020 $2,961.40 162
PY2021 $4,255.20 229
PY2022 $3,982.15 219
PY2023 $3,052.63 151
PY2024 $2,722.07 135
PY2025 $7,497.61 149

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $18,302.19 23
PY2024 Principal investigator $163,855.36 22
PY2023 Principal investigator $31,494.18 56
PY2022 Principal investigator $35,302.60 21

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

23 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Medtronic, Inc. $4,671.00 04/29/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328008
Principal investigator 1 Medtronic, Inc. $540.00 04/29/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328010
Principal investigator 1 Medtronic, Inc. $183.00 04/29/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328012
Principal investigator 1 Medtronic, Inc. $450.00 04/25/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328006
Principal investigator 1 Medtronic, Inc. $5,000.00 04/22/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328004
Principal investigator 1 Medtronic, Inc. $590.00 02/21/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328002
Principal investigator 1 Medtronic, Inc. $666.00 01/31/2025 Non-covered Recipient Entity
Javara Inc.
CIP341 IMPACT2 No dispute reported 06/30/2026 1192328000
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $148.50 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082092
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $74.25 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082094
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $256.50 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082096
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $2,162.02 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082098
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $81.00 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082100
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $20.79 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082102
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $64.80 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082104
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,081.01 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082106
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $128.25 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082108
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $74.25 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082110
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $256.50 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082112
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $1,081.01 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082114
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $81.00 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082116
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $646.31 01/24/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082118
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $16.50 01/02/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082120
Principal investigator 1 Rhythm Pharmaceuticals, Inc. $29.50 01/02/2025 Non-covered Recipient Entity
Javara Inc.
DAYBREAK: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway No dispute reported 06/30/2026 1240082122